Comparative <i>in vitro</i> activity of ceftazidime-avibactam plus aztreonam and the fixed combination aztreonam/avibactam against multidrug-resistant <i>Pseudomonas aeruginosa</i>
In vitro testing of CAZ/AVI + AZT revealed increased in vitro susceptibility among MDR P. aeruginosa isolates in comparison to the fixed combination of aztreonam/avibactam.
Authors
- Sabryna Junker (ORCID: https://orcid.org/0000-0001-9846-4505)
- Andreas Keller (ORCID: https://orcid.org/0000-0002-5361-0895)
- Jacqueline Rehner (ORCID: https://orcid.org/0000-0003-1335-4898)
- Leidy-Alejandra G Molano (ORCID: https://orcid.org/0000-0003-0069-6098)
- Sören L. Becker (ORCID: https://orcid.org/0000-0003-3634-8802)
- Sophie Elisabeth Müller (ORCID: https://orcid.org/0000-0002-2280-534X)
- Martin Förster (ORCID: https://orcid.org/0000-0003-3876-7269)
Institutions
- Institute of Medical Microbiology and Hygiene (DE)
- Helmholtz Institute for Pharmaceutical Research Saarland (DE)
- UCB Pharma (Belgium) (BE)
- Saarland University (DE)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-09-25
- DOI
- https://doi.org/10.1093/jac/dkaf376
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00